Detalhe da pesquisa
1.
Correlates of Dapivirine Vaginal Ring Acceptance among Women Participating in an Open Label Extension Trial.
AIDS Behav
; 27(3): 1030-1043, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36066762
2.
How Presentation of Drug Detection Results Changed Reports of Product Adherence in South Africa, Uganda and Zimbabwe.
AIDS Behav
; 22(3): 877-886, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28110473
3.
Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study).
PLoS One
; 18(6): e0287525, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352296
4.
Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial.
Lancet HIV
; 10(12): e779-e789, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37898146
5.
Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial.
J Womens Health (Larchmt)
; 26(6): 670-676, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28437215
6.
Bone Mineral Density Changes Among Young, Healthy African Women Receiving Oral Tenofovir for HIV Preexposure Prophylaxis.
J Acquir Immune Defic Syndr
; 71(3): 287-94, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26866954